In the weeds: A baseline view of cannabis use among legalizing states and their neighbours

Addiction

Volumn 111, Issue 6, 2016, Pages 973-980

  Pacula, Rosalie Liccardo ^a   Jacobson, Mireille ^b   Maksabedian, Ervant J ^a  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabis legalization; Medical cannabis; Mode of use; Recreational cannabis

Indexed keywords

MEDICAL CANNABIS;

ADOLESCENT; ADULT; AGED; CANNABIS USE; COLORADO; DRINKING BEHAVIOR; EPIDEMIOLOGY; FEMALE; HUMAN; LEGISLATION AND JURISPRUDENCE; MALE; MIDDLE AGED; NEW MEXICO; OREGON; QUESTIONNAIRE; VERY ELDERLY; WASHINGTON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; COLORADO; FEMALE; HUMANS; MALE; MARIJUANA USE; MEDICAL MARIJUANA; MIDDLE AGED; NEW MEXICO; OREGON; SURVEYS AND QUESTIONNAIRES; WASHINGTON; YOUNG ADULT;

EID: 84957990612     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13282     Document Type: Review

References (24)

1. Kleber H. D., DuPont R. L. Physicians and medical marijuana. Am J Psychiatry 2012; 169: 564-8.
2. Cohen P. J. Medical marijuana 2010: it's time to fix the regulatory vacuum. J Law Med Ethics 2010; 38: 654-66.
3. DuPont R. L. Examining the debate on the use of medical marijuana. Proc Assoc Am Physicians 1999; 111: 166-72.
4. Ogborne A. C., Smart R. G., Adlaf E. M. Self-reported medical use of marijuana: a survey of the general population. Can Med Assoc J 2000; 162: 1685-6.
5. Ware M. A., Adams H., Guy G. W. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005; 59: 291-5.
6. Ryan-Ibarra S., Induni M., Ewing D. Prevalence of medical marijuana use in California, 2012. Drug Alcohol Rev 2014; 34: 141-6.
7. Walsh Z., Callaway R., Belle-Isle L., Capler R., Kay R., Lucas P. et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. Int J Drug Policy, 2013; 24: 511-16.
8. Nunberg H., Kilmer B., Pacula R. L., Burgdorf J. R. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Anal 2011; 4: 1. doi:10.2202/1941-2851.1017.
9. O'Connell T. J., Bou-Matar C. B. Long term marijuana users seeking medical cannabis in California (2001--2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduct J 2007; 4: 16.
10. Ogborne A. C., Smart R. G., Weber T., Birchmore-Timney C. Who is using cannabis as a medicine and why: an exploratory study. J Psychoact Drugs, 2000; 32: 435-43.
11. Furler M. D., Einarson T. R., Millson M., Walmsley S., Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs 2004; 18: 215-28.
12. Woolridge E., Barton S., Samuel J., Osorio J., Dougherty A., Holdcroft A. et al. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 2005; 29: 358-67.
13. Prentiss D., Power R., Balmas G., Tzuang G., Israelski D. M. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J AIDS 2004; 35: 38-45.
14. Ware M. A., Doyle C. R., Woods R., Lynch M. E., Clark A. J. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102: 211-16.
15. Clark A. J., Ware M. A., Yazer E., Murray T. J., Lynch M. E. Patterns of cannabis use among patients with multiple sclerosis. Neurology 2004; 62: 2098-2100.
16. Page S. A., Verhoef M. J. Medicinal marijuana use: experiences of people with multiple sclerosis. Can Fam Physician 2006; 52: 64-5.
17. Hazekamp A., Ware M. A., Muller-Vahl K. R., Abrams D., Grotenhermen F. The medicinal use of cannabis and cannabinoids-an international cross-sectional survey on administration forms. J Psychoact Drugs 2013; 45: 199-210.
18. Malanick C. E., Pebley A. R., editors. Data priorities for population and health in developing countries: summary of a workshop. Washington, DC: National Academies Press; 1996.
19. Colorado Department of Public Health and Environment, Health and Environmental Informations and Statistics Division. Medical Use of Marijuana. Available at: https://www.colorado.gov/pacific/sites/default/files/CHEIS_MMJ_Medical-Use-of-Marijuana.pdf (Accessed on 21 December 2014). (Archived at http://www.webcitation.org/6eXYv1Kj9 on 14 January 2016).
20. Oregon Health Authority, The Oregon Medical Marijuana Program, Public Health Division Oregon Medical Marijuana Program (OMMP), PO Box 14 450 Portland, OR 97293-0450. Available at: https://public.health.oregon.gov/DiseasesConditions/ChronicDisease/MedicalMarijuanaProgram/Documents/ommpHandbook.pdf (Accessed on 21 December 2014). (Archived at http://www.webcitation.org/6eXZ64xIz on 14 January 2016).
21. Washington State Department of Health, Washington State Medical Marijuana Authorization Form, Medical Marijuana Program PO Box 47 852, Olympia, WA 98504-7852. Available at: http://www.doh.wa.gov/Portals/1/Documents/Pubs/630123.pdf (Accessed on 15 August 2015).
22. The Legislature of The State of New Mexico, The Lynn And Erin Compassionate Use Act, New Mexico Medical Cannabis Program, New Mexico Department of Health. Available at: http://nmhealth.org/publication/view/regulation/128/ (Accessed on 15 August 2015). (Archived at http://www.webcitation.org/6eXZTInKQ on 14 January 2016).
23. Earleywine M., Newcomb M. D. Concurrent versus simultaneous polydrug use: prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Exp Clin Psychopharmacol 1997; 5; 353.
24. Subbaraman M. S., Kerr W. C. Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey, Alcohol Clin Exp Res 2015; 39: 872-9. Available at: http://onlinelibrary.wiley.com/doi/10.1111/acer.12698/epdf (Accessed on 15 August 2015). (Archived at http://www.webcitation.org/6eXZde9W1 on 14 January 2016).